Risk stratification in patients with pulmonary arterial hypertension (PAH) and candidates for lung or heart-lung transplantation
H. Vicaire (Le Kremlin-Bicêtre, France), J. Le Pavec (Le Plessis Robinson, France), A. Boucly (Le Kremlin-Bicêtre, France), X. Jais (Le Kremlin-Bicêtre, France), O. Mercier (Le Plessis Robinson, France), D. Montani (Le Kremlin-Bicêtre, France), E. Fadel (Le Plessis Robinson, France), M. Humbert (Le Plessis Robinson, France), O. Sitbon (Le Plessis Robinson, France), L. Savale (Le Kremlin-Bicêtre, France)
Source: Virtual Congress 2021 – All about pulmonary arterial hypertension
Session: All about pulmonary arterial hypertension
Session type: Oral Presentation
Number: 141
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Vicaire (Le Kremlin-Bicêtre, France), J. Le Pavec (Le Plessis Robinson, France), A. Boucly (Le Kremlin-Bicêtre, France), X. Jais (Le Kremlin-Bicêtre, France), O. Mercier (Le Plessis Robinson, France), D. Montani (Le Kremlin-Bicêtre, France), E. Fadel (Le Plessis Robinson, France), M. Humbert (Le Plessis Robinson, France), O. Sitbon (Le Plessis Robinson, France), L. Savale (Le Kremlin-Bicêtre, France). Risk stratification in patients with pulmonary arterial hypertension (PAH) and candidates for lung or heart-lung transplantation. 141
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: